Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
May 13, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled CRSwNP, a condition driven in part by underlying type 2...
New high-grade zones discovered at North American Lithium
May 13, 2024 00:10 ET
|
Sayona Mining
Lithium producer Sayona Mining Limited (ASX:SYA; OTCQB:SYAXF), announces the discovery and expansion of new mineralised zones at North American Lithium
New Zealand’s 2degrees chooses Nokia 5G core software solutions running on Red Hat OpenShift
May 13, 2024 00:00 ET
|
Nokia Oyj
Press releaseNew Zealand’s 2degrees chooses Nokia 5G core software solutions running on Red Hat OpenShift Nokia Registers and Shared Data Layer swap out incumbent.Deal underlines...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Malibu Boats, and Altimmune and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exscientia, Akero, Equinix, and Harbor Diversified and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Autodesk, Global Cord, and Lincoln and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and Sharecare and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, and Compass Minerals and Encourages Investors to Contact the Firm
May 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
ArcScan's Insight® 100 眼科超声成像系统在中国获得批准
May 12, 2024 20:00 ET
|
ArcScan
丹佛, May 13, 2024 (GLOBE NEWSWIRE) -- ArcScan, Inc，一家致力于帮助眼科医生使用超高频超声诊断成像改善视力的全球医疗技术公司今天宣布 ArcScan Insight® 100 已获得中国国家药品监督管理局（NMPA)批准。 “我们相信 ArcScan Insight® 100...